Delivery Order SPE2DR25D3301-SPE2DR26F18NT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,914.07 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on December 4, 2025, with completion expected by December 5, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance based in Conshohocken, Pennsylvania, where the contractor maintains its corporate headquarters. The award falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $37,071.79 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Gemtesa 75 mg tablets (90-count units), with completion scheduled for October 30, 2025. The contract employs firm fixed pricing with no small business set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,855.36 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) with a firm fixed price structure. The contract is non-set-aside and competitively awarded, with an ultimate completion date of September 2, 2025. AmerisourceBergen will perform this delivery order from its corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) under a firm fixed-price contract valued at $7,349.03. The award, issued on November 6, 2025, with an ultimate completion date of November 7, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location, leveraging its...
- The Defense Logistics Agency awarded a delivery order valued at $17,747.75 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units). This firm fixed price delivery order, issued on November 25, 2025, with an ultimate completion date of November 26, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $22,337.44 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units). This firm fixed-price contract, issued on July 30, 2025, represents a non-competitive, non-set-aside award with an ultimate completion date of July 31, 2025. The pharmaceutical products will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $14,891.75 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90 count) on November 6, 2025, with completion scheduled for November 7, 2025. This firm fixed-price contract is a non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999.00 and extends through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,370.66 to AmerisourceBergen Drug Corp for 90 tablets of Gemtesa 75 mg, with delivery to the company's corporate office in Conshohocken, Pennsylvania. This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 15, 2025. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to...
- The Defense Logistics Agency awarded a delivery order valued at $1,279.87 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (30-count package) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and healthcare systems. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $7,531.09 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) on September 4, 2025, with completion expected by September 5, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running through December 2026. The order will be...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F18NTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,433.83 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count packages) with a completion date of November 25, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract with the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp serves as a critical vendor in the federal medical procurement system, with an extensive portfolio of delivery orders through the Defense Logistics Agency covering diverse pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The company's federal contracts demonstrate consistent capability to meet competitive procurement requirements through firm fixed-price arrangements. This award supports the Defense Health Agency and related government healthcare systems serving military personnel and veterans, positioning AmerisourceBergen as a key supplier within the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.4k | 11/23/25 |